Persimmon Leaf Polysaccharide Fraction for Immune Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for immune-related diseases often have adverse side effects and are not suitable for prevention, with a need for natural, side-effect-free alternatives that enhance immunity and address decreased immune function associated with aging or disease.
Innovation Solution
A persimmon leaf-derived polysaccharide fraction comprising 60-80% neutral sugar, 18-39% uronic acid, and 0.5-10% KDO analogs, prepared by treating persimmon leaf powder with pectinase and collecting fractions with molecular weights of 3-300 kDa and 5-30 kDa, which stimulates cytokine production and enhances Natural Killer cell activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used to treat immune-related diseases, then immune function can be improved, but adverse side effects occur
Solution Approach 1:
The patent uses a naturally derived polysaccharide fraction from persimmon leaves as a short-term, naturally degrading immune modulator that stimulates immune function without the cumulative toxicity of conventional long-term therapies. The natural origin and biodegradability of the polysaccharide ensure it provides immune support without persistent harmful effects.
Solution Approach 2:
The patent changes the parameter of immune stimulation from synthetic chemical compounds to natural polysaccharide structures with specific molecular weight ranges (3-300 kDa and 5-30 kDa fractions). This parameter change in the chemical nature of the immune modulator provides effective immune stimulation while avoiding the adverse side effects associated with conventional synthetic immunotherapies.
2Reliability
If conventional therapeutics are used for immune-related diseases, then treatment effects are achieved, but they are not suitable for prevention
Solution Approach 1:
The persimmon leaf polysaccharide fraction serves multiple functions: it can be used for both prevention and treatment of immune-related diseases. The natural polysaccharide provides broad immune modulation that is effective across different disease states, making it universally applicable for both preventive health maintenance and therapeutic intervention.
Solution Approach 2:
The polysaccharide fraction harnesses the body's own immune mechanisms to fight disease, rather than imposing external synthetic compounds. By stimulating the body's natural immune responses through natural polysaccharide structures, the treatment works synergistically with human physiology, making it suitable for both prevention and treatment across various immune-related conditions.
3Reliability
If immune function stimulators are used long term, then immune function is enhanced, but adverse side effects occur depending on individual immunity
Solution Approach 1:
The patent specifies particular molecular weight parameters for the polysaccharide fraction (3-300 kDa and 5-30 kDa ranges) which are critical for achieving effective immune stimulation without toxicity. These parameter specifications ensure the polysaccharide is small enough to be metabolized and eliminated safely, preventing cumulative adverse effects from long-term use while maintaining immunostimulating activity.
Solution Approach 2:
The natural polysaccharide fraction acts as a temporary immune stimulator that is naturally degraded and eliminated from the body, providing short-term immune enhancement without long-term accumulation. This allows for repeated use and long-term immune support without the progressive toxicity seen with conventional synthetic immunotherapies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polysaccharide fraction effectively enhances immune response, inhibits tumor metastasis, and is non-cytotoxic, making it suitable for food and pharmaceutical compositions to boost immunity and treat immune-related diseases, including cancer.
Implementation Method 1
treating persimmon leaf powder with pectinase
Data Source
AI summary
A persimmon leaf-derived polysaccharide fraction consisting of 60-80 wt % of neutral sugar and 18-39 wt % of uronic acid, and 0.5-10 wt % of 3-deoxy-D-manno-2-octulosonic acid (KDO) analogs, the wt % based on the total weight of the polysaccharide fraction.